APAC Therapeutic Access and Financing Trends to Watch in 2023
The market access and reimbursement landscape in APAC is set to shift in 2023, according to a new interview with Jeff… Read more
HEOR Feature
Featured
EMA Committee Announces Orphan Drug Application Changes to Improve Access to Rare Eye Disease Medications
Policies regarding orphan drug designations for a group of rare genetic eye diseases called inherited retinal dystrophies are changing, according to… Read more
US Sen. Warren Calls for March-In Rights for Prostate Cancer Drug
Elizabeth Warren (D-MA) and 25 other US senators wrote a letter to Department of Health and Human Services (HHS) Secretary Xavier Becerra requesting… Read more
Sonoma Pharma Seals Pricing and Distribution Arrangement, Spiking Share Prices
Sonoma Pharmaceuticals has announced that it has locked in a distribution and pricing deal with the Defense Logistics Agency. The announcement of the… Read more
The Latest Blogs from tHEORetically Speaking
- Will 2023 Be the Year AI Disrupts Healthcare?
- Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
- Podcast Q&A: Achieving Consensus When Everyone is an Expert, but No One Agrees
- Podcast Q&A: Social Media Data: Opportunities and Insights for Clinical Research
- Podcast Q&A: Making HEOR More Accessible to Patients
